Bevantolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263109This classification denotes a beta-adrenergic blocking agent with the molecular formula C20H27NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34ZXW6ZV21, chemically known as 2-propanol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)- but generally known as bevantolol, which bears US NIH Compound Identifier 2372. Bevantolol most often comes in base, hydrochloride, and metabolite forms. European Medicines Agency schedules Bevantolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05808MIG. The term BEVANTOLOL is an International Non-Proprietary Name. World Health Organization schedules bevantolol in its Anatomical Therapeutic Chemical (ATC) Classification. BEVANTOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bevantolol under HS 29225000 and SITC 51467. As of Q4 2014, BEVANTOLOL remains the US FDA Preferred Term for this commodity. Bevantolol bears US NLM identifiers UMLS ID C0053532 and NCI Concept Code C79556. SMILES: O(CC(O)CNCCC1CC(OC)C(OC)CC1)C1CC(CCC1)C.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.